According to a new study in mice supplements of niacin-bound chromium(III) may reduce blood pressure, thereby offering benefits to cardiovascular health.

Results of the new study indicate that niacin-bound chromium III (NBC) may act as an ACE inhibitor, which work by inhibiting the conversion of angiotensin I to the potent vasoconstrictor, angiotensin II, thereby improving blood flow and blood pressure.

ACE inhibitors made by drug companies have been found to be beneficial in treating hypertension, particularly in patients with type-1 or type-2 diabetes, and also appear to provide good cardiovascular and renal protection. Pharmaceutical ACE-inhibitors do however have side effects.

Well...let's wait and see if the same is true in human trials, right?

Find more details from NutraIngredients.

[In Photo: The Nutritional Biochemistry of Chromium(III) (Hardcover) by John Vincent (Editor), available from Amazon]